• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    8/7/23 12:13:28 PM ET
    $XAIR
    $YJ
    $ZI
    $ZVIA
    Medical/Dental Instruments
    Health Care
    Other Specialty Stores
    Consumer Discretionary
    Get the next $XAIR alert in real time by email

     

    On Monday, 149 companies reached new 52-week lows.

    Noteable 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was NextEra Energy (NYSE:NEE).
    • The smallest company by market cap to hit a new 52-week low was Esports Entertainment (NASDAQ:GMBL).
    • Bionano Genomics (NASDAQ:BNGO) saw the most pronounced move, as shares traded down 842.14% to hit its new 52-week low.
    • Northwest Natural Hldg (NYSE:NWN) shares actually gained 0.0%, rebounding after it reached its 52-week low.

    Here are all the stocks that set new 52-week lows on Monday:

    • NextEra Energy (NYSE:NEE) shares fell to $68.94 on Monday, setting a new 52-week low with a shift of down 0.21%.
    • Estee Lauder Cos (NYSE:EL) shares made a new 52-week low of $169.89 on Monday. The stock was up 0.01% for the day.
    • General Mills (NYSE:GIS) stock achieved a new 52-week low on Monday morning, hitting $73.32 and moving up 0.14%.
    • Moderna (NASDAQ:MRNA) stock hit a new 52-week low of $98.72. The stock was down 7.91% on the session.
    • BioNTech (NASDAQ:BNTX) stock hit a new 52-week low of $95.51. The stock was down 10.17% on the session.
    • Enphase Energy (NASDAQ:ENPH) stock set a new 52-week low of $134.80 on Monday, moving down 2.37%.
    • Campbell Soup (NYSE:CPB) stock achieved a new 52-week low on Monday morning, hitting $44.21 and moving down 1.37%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a yearly low of $180.08. The stock was down 0.59% for the day.
    • ZoomInfo Technologies (NASDAQ:ZI) stock drifted down 1.08% on Monday morning to hit a new 52-week low of $18.22.
    • Valmont Industries (NYSE:VMI) shares fell to $253.07 on Monday, setting a new 52-week low with a shift of up 0.34%.
    • UGI (NYSE:UGI) stock drifted up 0.92% on Monday morning to hit a new 52-week low of $24.26.
    • NextEra Energy Partners (NYSE:NEP) shares set a new 52-week low of $49.68. The stock traded down 0.86%.
    • Clarivate (NYSE:CLVT) stock drifted down 0.66% on Monday morning to hit a new 52-week low of $6.59.
    • Cerevel Therapeutics Hldg (NASDAQ:CERE) shares reached a new 52-week low of $20.93 on Monday morning, moving down 6.41%.
    • WNS (Hldgs) (NYSE:WNS) shares set a new yearly low of $66.22 this morning. The stock was down 1.15% on the session.
    • NovoCure (NASDAQ:NVCR) shares moved down 5.92% on Monday to hit a new 52-week low of $26.73, drifting down 5.92%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) shares set a new 52-week low of $19.83. The stock traded down 4.95%.
    • Fortrea Holdings (NASDAQ:FTRE) shares set a new 52-week low of $28.37. The stock traded up 0.71%.
    • Sensient Technologies (NYSE:SXT) stock achieved a new 52-week low on Monday morning, hitting $61.03 and moving up 0.54%.
    • Mister Car Wash (NYSE:MCW) stock drifted down 2.02% on Monday morning to hit a new 52-week low of $7.14.
    • Equity Commonwealth (NYSE:EQC) shares fell to $19.17 on Monday, setting a new 52-week low with a shift of up 0.7%.
    • Beam Therapeutics (NASDAQ:BEAM) shares fell to $25.87 on Monday, setting a new 52-week low with a shift of down 3.8%.
    • JinkoSolar Holding Co (NYSE:JKS) shares reached a new 52-week low of $37.78 on Monday morning, moving up 0.43%.
    • Mirati Therapeutics (NASDAQ:MRTX) shares hit a yearly low of $28.13. The stock was down 3.67% on the session.
    • Delek Logistics Partners (NYSE:DKL) stock broke to a new 52-week low of $36.80 on Monday. Shares of the company traded down 9.22%.
    • Impinj (NASDAQ:PI) shares reached a new 52-week low of $59.76 on Monday morning, moving down 1.06%.
    • SunPower (NASDAQ:SPWR) shares set a new yearly low of $8.51 this morning. The stock was down 0.35% on the session.
    • Northwest Natural Hldg (NYSE:NWN) stock dropped to a yearly low on Monday of $40.90. Shares traded 0.0% (flat).
    • TTEC Holdings (NASDAQ:TTEC) stock achieved a new 52-week low on Monday morning, hitting $30.58 and moving down 4.38%.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) shares hit a yearly low of $18.83. The stock was down 3.09% on the session.
    • Nu Skin Enterprises (NYSE:NUS) shares were up 0.27% for the day, having made a 52-week low of $25.88.
    • Harmonic (NASDAQ:HLIT) shares set a new 52-week low of $10.58. The stock traded down 3.89%.
    • Sage Therapeutics (NASDAQ:SAGE) stock dropped to a yearly low on Monday of $17.50. Shares traded down 50.89%.
    • Genesis Energy (NYSE:GEL) shares set a new yearly low of $8.06 this morning. The stock was down 1.03% on the session.
    • Infinera (NASDAQ:INFN) stock hit $3.90 on Monday morning, setting a new 52-week low for a change of down 2.12%.
    • Allogene Therapeutics (NASDAQ:ALLO) shares moved down 6.32% on Monday to hit a new 52-week low of $4.27, drifting down 6.32%.
    • Avidity Biosciences (NASDAQ:RNA) stock broke to a new 52-week low of $8.85 on Monday. Shares of the company traded down 3.02%.
    • CryoPort (NASDAQ:CYRX) stock set a new 52-week low of $13.52 on Monday, moving down 4.29%.
    • GoPro (NASDAQ:GPRO) shares fell to $3.65 on Monday, setting a new 52-week low with a shift of up 0.27%.
    • American Well (NYSE:AMWL) stock set a new 52-week low of $1.87 on Monday, moving down 3.41%.
    • Adtran (NASDAQ:ADTN) shares hit a yearly low of $7.00. The stock was down 20.83% on the session.
    • John Hancock Premium Div (NYSE:PDT) shares made a new 52-week low of $10.90 on Monday. The stock was down 0.34% for the day.
    • Mineralys Therapeutics (NASDAQ:MLYS) stock hit a yearly low of $12.02. The stock was down 6.77% for the day.
    • Baijiayun Group (NASDAQ:RTC) shares were down 4.34% for the day, having made a 52-week low of $5.41.
    • IGM Biosciences (NASDAQ:IGMS) shares fell to $8.06 on Monday, setting a new 52-week low with a shift of down 10.54%.
    • Fate Therapeutics (NASDAQ:FATE) stock broke to a new 52-week low of $3.48 on Monday. Shares of the company traded down 6.17%.
    • Repare Therapeutics (NASDAQ:RPTX) stock hit $8.09 on Monday morning, setting a new 52-week low for a change of down 3.55%.
    • Entravision Comms (NYSE:EVC) shares were up 0.65% for the day, having made a 52-week low of $3.64.
    • Funko (NASDAQ:FNKO) shares reached a new 52-week low of $6.11 on Monday morning, moving down 0.71%.
    • Anika Therapeutics (NASDAQ:ANIK) shares set a new 52-week low of $21.33. The stock traded down 2.29%.
    • 2seventy bio (NASDAQ:TSVT) stock hit a new 52-week low of $5.78. The stock was down 3.29% on the session.
    • Hanryu Holdings (NASDAQ:HRYU) stock drifted down 7.0% on Monday morning to hit a new 52-week low of $5.31.
    • Stoke Therapeutics (NASDAQ:STOK) shares fell to $5.39 on Monday, setting a new 52-week low with a shift of down 3.27%.
    • Nutex Health (NASDAQ:NUTX) stock hit $0.37 on Monday morning, setting a new 52-week low for a change of down 1.45%.
    • BRC (NYSE:BRCC) shares made a new 52-week low of $4.05 on Monday. The stock was down 0.97% for the day.
    • Gold Royalty (AMEX:GROY) stock set a new 52-week low of $1.64 on Monday, moving down 1.79%.
    • Braemar Hotels & Resorts (NYSE:BHR) shares were up 0.91% for the day, having made a 52-week low of $3.23.
    • SWK Holdings (NASDAQ:SWKH) stock hit a new 52-week low of $15.85. The stock was up 1.81% on the session.
    • Adaptimmune Therapeutics (NASDAQ:ADAP) stock hit $0.85 on Monday morning, setting a new 52-week low for a change of down 2.27%.
    • Burning Rock Biotech (NASDAQ:BNR) shares set a new yearly low of $1.66 this morning. The stock was down 3.33% on the session.
    • Inogen (NASDAQ:INGN) stock hit a yearly low of $7.37. The stock was down 0.66% for the day.
    • NGM Biopharmaceuticals (NASDAQ:NGM) shares were down 8.6% for the day, having made a 52-week low of $2.00.
    • Akoustis Technologies (NASDAQ:AKTS) stock set a new 52-week low of $2.19 on Monday, moving down 0.35%.
    • Kezar Life Sciences (NASDAQ:KZR) shares fell to $2.07 on Monday, setting a new 52-week low with a shift of down 2.58%.
    • ContextLogic (NASDAQ:WISH) shares fell to $5.85 on Monday, setting a new 52-week low with a shift of down 3.69%.
    • Honest Co (NASDAQ:HNST) stock broke to a new 52-week low of $1.35 on Monday. Shares of the company traded down 2.13%.
    • Zevia (NYSE:ZVIA) stock dropped to a yearly low on Monday of $2.43. Shares traded down 0.79%.
    • Vicarious Surgical (NYSE:RBOT) shares made a new 52-week low of $0.83 on Monday. The stock was down 9.37% for the day.
    • G1 Therapeutics (NASDAQ:GTHX) stock hit a yearly low of $2.05. The stock was down 3.69% for the day.
    • Gorilla Tech Gr (NASDAQ:GRRR) shares reached a new 52-week low of $1.53 on Monday morning, moving down 7.62%.
    • Cherry Hill Mortgage (NYSE:CHMI) stock hit $4.09 on Monday morning, setting a new 52-week low for a change of down 1.56%.
    • Beyond Air (NASDAQ:XAIR) stock dropped to a yearly low on Monday of $3.14. Shares traded down 3.36%.
    • DZS (NASDAQ:DZSI) shares hit a yearly low of $3.06. The stock was down 3.74% on the session.
    • Chimerix (NASDAQ:CMRX) shares set a new yearly low of $1.04 this morning. The stock was down 3.96% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) shares fell to $5.40 on Monday, setting a new 52-week low with a shift of up 3.33%.
    • Clene (NASDAQ:CLNN) stock hit $0.69 on Monday morning, setting a new 52-week low for a change of down 2.6%.
    • Eargo (NASDAQ:EAR) stock dropped to a yearly low on Monday of $3.71. Shares traded down 1.84%.
    • Affimed (NASDAQ:AFMD) stock achieved a new 52-week low on Monday morning, hitting $0.45 and moving down 16.67%.
    • CEL-SCI (AMEX:CVM) shares moved down 8.39% on Monday to hit a new 52-week low of $1.33, drifting down 8.39%.
    • Village Farms Intl (NASDAQ:VFF) stock hit a new 52-week low of $0.55. The stock was down 1.41% on the session.
    • Dare Bioscience (NASDAQ:DARE) shares reached a new 52-week low of $0.66 on Monday morning, moving down 4.79%.
    • Neuronetics (NASDAQ:STIM) stock set a new 52-week low of $1.80 on Monday, moving down 3.65%.
    • MSP Recovery (NASDAQ:LIFW) shares set a new 52-week low of $0.14. The stock traded up 3.59%.
    • Marti Techs (AMEX:MRT) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 6.8%.
    • Surf Air Mobility (NYSE:SRFM) shares set a new 52-week low of $1.32. The stock traded down 3.6%.
    • Near Intelligence (NASDAQ:NIR) shares were down 9.24% for the day, having made a 52-week low of $0.86.
    • CareCloud (NASDAQ:CCLD) shares moved down 1.68% on Monday to hit a new 52-week low of $2.47, drifting down 1.68%.
    • Splash Beverage Group (AMEX:SBEV) stock hit a yearly low of $0.71. The stock was down 10.66% for the day.
    • Neonode (NASDAQ:NEON) stock hit a new 52-week low of $1.95. The stock was down 8.41% on the session.
    • Fusion Fuel Green (NASDAQ:HTOO) stock dropped to a yearly low on Monday of $2.03. Shares traded down 1.96%.
    • Interactive Strength (NASDAQ:TRNR) shares set a new yearly low of $1.61 this morning. The stock was down 5.24% on the session.
    • Earlyworks Co (NASDAQ:ELWS) stock set a new 52-week low of $1.60 on Monday, moving down 1.46%.
    • SatixFy Communications (AMEX:SATX) shares set a new 52-week low of $0.31. The stock traded down 3.03%.
    • NRX Pharmaceuticals (NASDAQ:NRXP) stock broke to a new 52-week low of $0.34 on Monday. Shares of the company traded up 1.4%.
    • Yunji (NASDAQ:YJ) stock hit $0.95 on Monday morning, setting a new 52-week low for a change of down 0.99%.
    • Trio Petroleum (AMEX:TPET) stock hit a new 52-week low of $0.67. The stock was down 1.41% on the session.
    • Vaccinex (NASDAQ:VCNX) shares made a new 52-week low of $0.26 on Monday. The stock was down 3.99% for the day.
    • Cineverse (NASDAQ:CNVS) stock hit a new 52-week low of $1.40. The stock was down 2.72% on the session.
    • Cosmos Health (NASDAQ:COSM) stock drifted down 0.85% on Monday morning to hit a new 52-week low of $1.11.
    • Visionary Education Tech (NASDAQ:VEDU) shares were up 3.75% for the day, having made a 52-week low of $0.33.
    • voxeljet (NASDAQ:VJET) shares made a new 52-week low of $1.51 on Monday. The stock was down 2.24% for the day.
    • WANG & LEE Group (NASDAQ:WLGS) stock set a new 52-week low of $0.74 on Monday, moving up 8.84%.
    • Aravive (NASDAQ:ARAV) stock hit a new 52-week low of $0.21. The stock was down 12.0% on the session.
    • Addentax Group (NASDAQ:ATXG) stock drifted down 6.34% on Monday morning to hit a new 52-week low of $3.05.
    • Sidus Space (NASDAQ:SIDU) shares were down 0.8% for the day, having made a 52-week low of $0.14.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares made a new 52-week low of $0.81 on Monday. The stock was down 4.61% for the day.
    • Athersys (NASDAQ:ATHX) stock broke to a new 52-week low of $0.50 on Monday. Shares of the company traded down 10.83%.
    • Treasure Global (NASDAQ:TGL) shares set a new 52-week low of $0.60. The stock traded down 7.26%.
    • 60 Degrees (NASDAQ:SXTP) stock broke to a new 52-week low of $1.82 on Monday. Shares of the company traded 0.0% (flat).
    • KWESST Micro Systems (NASDAQ:KWE) shares set a new 52-week low of $1.81. The stock traded down 7.5%.
    • ShiftPixy (NASDAQ:PIXY) stock hit a new 52-week low of $0.86. The stock was down 3.15% on the session.
    • Infinity Pharmaceuticals (NASDAQ:INFI) stock broke to a new 52-week low of $0.10 on Monday. Shares of the company traded down 16.5%.
    • Branchout Food (NASDAQ:BOF) shares were up 0.44% for the day, having made a 52-week low of $2.11.
    • Golden Minerals (AMEX:AUMN) stock drifted down 2.61% on Monday morning to hit a new 52-week low of $1.13.
    • China Jo-Jo Drugstores (NASDAQ:CJJD) stock drifted down 5.38% on Monday morning to hit a new 52-week low of $0.36.
    • Fangdd Network Group (NASDAQ:DUO) shares reached a new 52-week low of $2.12 on Monday morning, moving down 15.68%.
    • Taoping (NASDAQ:TAOP) stock achieved a new 52-week low on Monday morning, hitting $3.50 and moving down 12.96%.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) shares fell to $3.09 on Monday, setting a new 52-week low with a shift of up 0.57%.
    • Redhill Biopharma (NASDAQ:RDHL) stock hit a new 52-week low of $1.00. The stock was down 2.86% on the session.
    • SMX (Security Matters) (NASDAQ:SMX) shares made a new 52-week low of $0.11 on Monday. The stock was down 1.47% for the day.
    • Panbela Therapeutics (NASDAQ:PBLA) stock hit $1.53 on Monday morning, setting a new 52-week low for a change of down 4.14%.
    • NanoVibronix (NASDAQ:NAOV) stock dropped to a yearly low on Monday of $2.59. Shares traded down 0.71%.
    • Synaptogenix (NASDAQ:SNPX) shares moved down 7.89% on Monday to hit a new 52-week low of $0.60, drifting down 7.89%.
    • Evoke Pharma (NASDAQ:EVOK) stock achieved a new 52-week low on Monday morning, hitting $1.35 and moving down 10.46%.
    • Aptevo Therapeutics (NASDAQ:APVO) shares hit a yearly low of $0.56. The stock was down 4.35% on the session.
    • Soligenix (NASDAQ:SNGX) stock hit $0.51 on Monday morning, setting a new 52-week low for a change of down 9.04%.
    • Digital Brands Group (NASDAQ:DBGI) stock hit a new 52-week low of $0.41. The stock was down 0.53% on the session.
    • Akerna (NASDAQ:KERN) stock hit $0.43 on Monday morning, setting a new 52-week low for a change of down 8.17%.
    • Aditxt (NASDAQ:ADTX) shares set a new yearly low of $0.38 this morning. The stock was up 1.18% on the session.
    • Avalo Therapeutics (NASDAQ:AVTX) stock hit $0.15 on Monday morning, setting a new 52-week low for a change of down 7.71%.
    • Akanda (NASDAQ:AKAN) shares set a new 52-week low of $0.54. The stock traded down 2.13%.
    • Harbor Custom Dev (NASDAQ:HCDI) stock hit a new 52-week low of $2.25. The stock was down 4.32% on the session.
    • Galmed Pharmaceuticals (NASDAQ:GLMD) shares fell to $0.92 on Monday, setting a new 52-week low with a shift of down 9.52%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares hit a yearly low of $2.03. The stock was down 7.14% on the session.
    • Esports Entertainment (NASDAQ:GMBL) shares set a new 52-week low of $0.26. The stock traded down 20.83%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $XAIR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XAIR
    $YJ
    $ZI
    $ZVIA

    CompanyDatePrice TargetRatingAnalyst
    Zevia PBC
    $ZVIA
    2/26/2026$6.00 → $5.00Outperform
    Telsey Advisory Group
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Stoke Therapeutics Inc.
    $STOK
    2/24/2026$40.00Outperform
    Wolfe Research
    Mister Car Wash Inc.
    $MCW
    2/23/2026$7.00Overweight → Neutral
    Analyst
    General Mills Inc.
    $GIS
    2/23/2026$48.00Buy → Neutral
    BofA Securities
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    SolarEdge Technologies Inc.
    $SEDG
    2/19/2026$38.00 → $43.00Buy
    TD Cowen
    More analyst ratings

    $XAIR
    $YJ
    $ZI
    $ZVIA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    August 4, 2023 - La FDA aprueba el primer tratamiento oral para la depresión posparto

    For Immediate Release: August 04, 2023 El día de hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó Zurzuvae (zuranolona), el primer medicamento oral indicado para tratar la depresión posparto (DPP) en mujeres adultas. La DPP es un episodio depresivo grave que generalmente ocurre después del parto, pero también puede comenzar durante las últimas etapas

    8/8/23 9:34:19 AM ET
    $SAGE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

    BOSTON, Feb. 27, 2026 /PRNewswire/ - John Hancock Premium Dividend Fund (NYSE:PDT) (the "Fund"), a closed-end fund managed by John Hancock Investment Management LLC and subadvised by Manulife Investment Management (US) LLC, announced today sources of its monthly distribution of $0.0825 per share paid to all shareholders of record as of February 12, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission. Notification of Sources of DistributionThis notice provides shareholders of the John Hancock Premium Dividend Fund (NYSE:PDT) with important information concernin

    2/27/26 4:44:00 PM ET
    $PDT
    Finance Companies
    Finance

    Novocure to Participate in 2026 Leerink Global Healthcare Conference

    Novocure (NASDAQ:NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 10, 2026. Frank Leonard, Chief Executive Officer, and Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 11:20 a.m. EST, as well as one-on-one meetings with investors throughout the event. A live audio webcast of this presentation can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive for

    2/27/26 4:30:00 PM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies

    Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform Lead candidates ATR 1072 and ATR 1086 expected to enter clinical trials for PRKAG2 syndrome and PLN cardiomyopathy, respectivelySAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (NASDAQ:RNA) launched today as a newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, life-threatening genetic cardiomyopathies. Atrium Therapeutics was established in connection with Avidity Biosciences, Inc.'s acquisition by Novartis AG. The company is led by Kathl

    2/27/26 9:19:00 AM ET
    $RNA

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CFO Lindsey Mark Wayne bought $70,000 worth of shares (35,000 units at $2.00), increasing direct ownership by 29% to 154,168 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:43 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chief Motion Pictures Officer Macias Yolanda sold $5,297 worth of shares (2,189 units at $2.42) and bought $60,000 worth of shares (30,000 units at $2.00), increasing direct ownership by 30% to 121,760 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:04 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Zevia PBC with a new price target

    Telsey Advisory Group reiterated coverage of Zevia PBC with a rating of Outperform and set a new price target of $5.00 from $6.00 previously

    2/26/26 6:51:04 AM ET
    $ZVIA
    Beverages (Production/Distribution)
    Consumer Staples

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    Wolfe Research initiated coverage on Stoke Therapeutics with a new price target

    Wolfe Research initiated coverage of Stoke Therapeutics with a rating of Outperform and set a new price target of $40.00

    2/24/26 7:56:29 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XAIR
    $YJ
    $ZI
    $ZVIA
    SEC Filings

    View All

    Amendment: SEC Form F-1/A filed by SMX (Security Matters) Public Limited Company

    F-1/A - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/27/26 5:01:28 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    Amendment: Braemar Hotels & Resorts Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - Braemar Hotels & Resorts Inc. (0001574085) (Filer)

    2/27/26 4:54:36 PM ET
    $BHR
    Real Estate Investment Trusts
    Real Estate

    SEC Form S-8 filed by Inogen Inc

    S-8 - Inogen Inc (0001294133) (Filer)

    2/27/26 4:33:26 PM ET
    $INGN
    Industrial Specialties
    Health Care

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP, Treas, Controller & CAO Wilson Brody J was granted 3,066 shares, increasing direct ownership by 25% to 15,430 units (SEC Form 4)

    4 - Northwest Natural Holding Co (0001733998) (Issuer)

    2/27/26 5:26:10 PM ET
    $NWN
    Oil/Gas Transmission
    Utilities

    VP, Regulatory Affairs and Kravitz Zachary D was granted 2,838 shares, increasing direct ownership by 138% to 3,876 units (SEC Form 4)

    4 - Northwest Natural Holding Co (0001733998) (Issuer)

    2/27/26 5:08:06 PM ET
    $NWN
    Oil/Gas Transmission
    Utilities

    SVP & Chief Financial Officer Kaszuba Raymond J Iii was granted 1,689 shares, increasing direct ownership by 24% to 8,741 units (SEC Form 4)

    4 - Northwest Natural Holding Co (0001733998) (Issuer)

    2/27/26 5:05:48 PM ET
    $NWN
    Oil/Gas Transmission
    Utilities

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Financials

    Live finance-specific insights

    View All

    JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

    BOSTON, Feb. 27, 2026 /PRNewswire/ - John Hancock Premium Dividend Fund (NYSE:PDT) (the "Fund"), a closed-end fund managed by John Hancock Investment Management LLC and subadvised by Manulife Investment Management (US) LLC, announced today sources of its monthly distribution of $0.0825 per share paid to all shareholders of record as of February 12, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission. Notification of Sources of DistributionThis notice provides shareholders of the John Hancock Premium Dividend Fund (NYSE:PDT) with important information concernin

    2/27/26 4:44:00 PM ET
    $PDT
    Finance Companies
    Finance

    Delek US Holdings Reports Fourth Quarter 2025 Results

     Delek US reported fourth quarter net income of $78.3 million or $1.26 per share, adjusted net income of $143.0 million or $2.31 per share and adjusted EBITDA of $374.8 million Excluding the impacts of SREs, adjusted EPS was $0.44 per share and adjusted EBITDA was $225.5 million Further advanced key objectives of Enterprise Optimization Plan ("EOP") Increased the annual run-rate cash flow improvements to ~$200 million Recognized ~$50 million of improvements in 4Q'25 Announced restructuring of its Inventory Intermediation Agreement which will result in incremental free cash flow generation of at least $40 million Delek Logistics reported record financial performance and

    2/27/26 6:30:00 AM ET
    $DK
    $DKL
    Integrated oil Companies
    Energy
    Natural Gas Distribution

    Delek Logistics Reports Record Fourth Quarter 2025 Results

    Delek Logistics reported Net income of $47.3 million or $0.88 per unit Delivered record financial performance, Adjusted EBITDA of $142.3 million for the fourth quarter and $535.6 million for the year Progressed comprehensive acid gas injection (AGI) & sour gas treating solution at the Libby Gas Complex Initiated 2026 EBITDA Guidance of $520 - 560 million 2026 guidance reflects Increased economic separation from DK, as third-party EBITDA contribution to exceed 80% Continued our consistent distribution growth with our 52nd consecutive quarterly increase to $1.125/unit Delek Logistics Partners, LP (NYSE:DKL) ("Delek Logistics") today announced its financial results for the f

    2/27/26 6:30:00 AM ET
    $DKL
    Natural Gas Distribution
    Energy

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Leadership Updates

    Live Leadership Updates

    View All

    Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

    SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano's Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that could be the future of digital cytogenetics

    2/27/26 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    $XAIR
    $YJ
    $ZI
    $ZVIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance